Polymeric coatings
are a promising option for the development of
delivery systems for orally administered drugs. However, the gastrointestinal
conditions to which they are subjected, which include low pH and solubility
as well as peristaltic movements, can limit their applications. In
this work, different formulations of polymeric coatings were produced
using pH-sensitive materials consisting of copolymers of methyl acrylate,
methyl methacrylate, and methacrylic acid. The polymers were synthesized
by the emulsion polymerization technique, obtaining small average
particle sizes (56–190 nm), molecular weights between 200,000
and 400,000 g/mol, and a glass transition temperature above 35 °C,
which are suitable for film formation at room temperature. Thus, they
were assessed as coatings for hydroxypropyl methylcellulose capsules
(HPMC) using the immersion method, showing adequate capacity to protect
the capsule at gastric pH (pH 1.2) and dissolve at the simulated intestinal
pH (pH= 7.2). In particular, the higher the content of the acidic
monomer, the higher the release time of the test molecule contained
in the acrylic terpolymer-coated HPMC capsules proposed, which was
a curcuminoid derivative due to their bright color and potential medical
benefits. In addition, a minimum number of immersions was required
for coating the HPMC capsules at high acidic concentrations, which
further facilitates the delayed release needed for colonic treatment.
However, too high proportions of methacrylic acid may result in cytotoxicity
issues. Consequently, a biocompatible formulation containing a proportion
of methyl acrylate, methyl methacrylate, and methacrylic acid of 7:3:3
is proposed as the most adequate for colonic release. Thus, by chemically
modulating the molar percentages of the acrylic monomers, it was possible
to obtain tailored acrylic terpolymer coatings with different characteristics
and desired properties in order to modulate the release kinetics of
an active substance in a colonic environment.